Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 579

Lactase from Bifidobacterium bifidum produced in Bacillus subtilis

Intended Use: For use in the production of galacto-oligosaccharide for infant formula and in the production of fresh dairy products
Basis: Scientific procedures
Notifier: Danisco US Inc.
Notifier Address: 925 Page Mill Road, Palo Alto, CA 94304
Date of filing: May 21, 2015
GRAS Notice (releasable information): GRN 579 (in PDF) (666 kB)
Date of closure: Nov 5, 2015
FDA's Letter: FDA has no questions
-
-